INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 42h ago
House PTR2h ago
SEC 13F2h ago
Robinhood Chain2h ago

Results

77,304 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
5
SS
Skates SpenserDirector, CEO and President, 10% Owner
AMPLAmplitude, Inc.
Grant or award
A—
1.32M sh
Apr 21, 2026Apr 22, 2026
Page 1096 of 1933
← PrevNext →
traded Apr 21, 2026
+1d
SEC Form 4

Evidence

5
FD
Feldman Jason D.SVP, IR, Treasury & Tax
CRCrane Co
Tax withholding
F$16K
83 sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC Form 4

Evidence

5
SH
Sehmi HarminderChief Financial Officer
BZAIBlaize Holdings, Inc.
Option exercise · 10b5-1 plan
M$288K
505.1K sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC Form 4

Evidence

5
FD
Feldman Jason D.SVP, IR, Treasury & Tax
CRCrane Co
Option exercise
M—
162 sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC Form 4

Evidence

5
CE
Collins Charles Edwin IVCHIEF EXECUTIVE OFFICER, GEMMA
AGXARGAN INC
Option exercise
M$31K
500 sh
Apr 21, 2026Apr 22, 2026
traded Apr 21, 2026
+1dSEC Form 4

Evidence

5
CE
Collins Charles Edwin IVCHIEF EXECUTIVE OFFICER, GEMMA
AGXARGAN INC
Option exercise
M$50K
333 sh
Apr 21, 2026Apr 22, 2026
traded Apr 21, 2026
+1dSEC Form 4

Evidence

4
CS
Cross ShawnChief Financial Officer
PCRXPacira BioSciences, Inc.
Open-market sale · 10b5-1 plan
SELL$71K
2,845 sh
Apr 21, 2026Apr 22, 2026
traded Apr 21, 2026
+1dSEC Form 4

Evidence

4
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
200.0K sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC Form 4

Evidence

3
HI
Hyep IvanChief Financial Officer
BCAXBicara Therapeutics Inc.
Option exercise · 10b5-1 plan
M—
9,200 sh
Apr 21, 2026Apr 22, 2026
traded Apr 21, 2026
+1dSEC Form 4

Evidence

2
FD
Faga DanielDirector, President, CEO
ANABANAPTYSBIO, INC
Disposition to issuer
D—
9,200 sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC Form 4

Evidence

2
KA
Kuykendall AnneSVP and Chief Legal Officer
PENGPenguin Solutions, Inc.
Tax withholding · 10b5-1 plan
F$82K
3,062 sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC Form 4

Evidence

2
FD
Faga DanielDirector, President, CEO
ANABANAPTYSBIO, INC
Grant or award
A—
133.4K sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC Form 4

Evidence

2
FD
Faga DanielDirector, President, CEO
ANABANAPTYSBIO, INC
Grant or award
A—
2,321 sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC Form 4

Evidence

2
FD
Faga DanielDirector, President, CEO
ANABANAPTYSBIO, INC
Disposition to issuer
D—
305.5K sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC Form 4

Evidence

2
FD
Faga DanielDirector, President, CEO
ANABANAPTYSBIO, INC
Grant or award
A—
11.0K sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC Form 4

Evidence

2
FD
Faga DanielDirector, President, CEO
ANABANAPTYSBIO, INC
Disposition to issuer
D—
194.9K sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC Form 4

Evidence

2
FD
Faga DanielDirector, President, CEO
ANABANAPTYSBIO, INC
Grant or award
A—
305.5K sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC Form 4

Evidence

2
FD
Faga DanielDirector, President, CEO
ANABANAPTYSBIO, INC
Grant or award
A—
194.9K sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC Form 4

Evidence

2
FD
Faga DanielDirector, President, CEO
ANABANAPTYSBIO, INC
Disposition to issuer
D—
133.4K sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC Form 4

Evidence

2
FD
Faga DanielDirector, President, CEO
ANABANAPTYSBIO, INC
Grant or award
A—
9,200 sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC Form 4

Evidence

2
FD
Faga DanielDirector, President, CEO
ANABANAPTYSBIO, INC
Disposition to issuer
D—
379.6K sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC Form 4

Evidence

2
FD
Faga DanielDirector, President, CEO
ANABANAPTYSBIO, INC
Disposition to issuer
D—
2,321 sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC Form 4

Evidence

2
FD
Faga DanielDirector, President, CEO
ANABANAPTYSBIO, INC
Grant or award
A—
379.6K sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC Form 4

Evidence

1
FL
Freemen-Bosworth LaurenEVP/Gen Counsel & Corp Sec
PBIPITNEY BOWES INC /DE/
Open-market sale · 10b5-1 plan
SELL$2,408
169 sh
Apr 21, 2026Apr 22, 2026
traded Apr 21, 2026
+1dSEC Form 4

Evidence

1
CS
Cross ShawnChief Financial Officer
PCRXPacira BioSciences, Inc.
Open-market sale · 10b5-1 plan
SELL$38K
1,500 sh
Apr 22, 2026Apr 22, 2026
traded Apr 22, 2026
+0dSEC Form 4

Evidence

0
MI
Mecklenburg Gabriel M.I.Director, Exec. Chairman & Co-Founder
HNGEHinge Health, Inc.
Derivative conversion · 10b5-1 plan
C—
33.3K sh
Apr 21, 2026Apr 22, 2026
traded Apr 21, 2026
+1dSEC Form 4

Evidence

0
OO
Okupe OluyemiChief Financial Officer
HIMSHims & Hers Health, Inc.
Option exercise · 10b5-1 plan
M—
5,553 sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC Form 4

Evidence

0
CS
Cross ShawnChief Financial Officer
PCRXPacira BioSciences, Inc.
Option exercise · 10b5-1 plan
M—
2,845 sh
Apr 21, 2026Apr 22, 2026
traded Apr 21, 2026
+1dSEC Form 4

Evidence

0
AP
Adarkar PrabirPRESIDENT AND COO
DASHDoorDash, Inc.
Option exercise · 10b5-1 plan
M—
10.0K sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC Form 4

Evidence

0
OO
Okupe OluyemiChief Financial Officer
HIMSHims & Hers Health, Inc.
Option exercise · 10b5-1 plan
M$81K
7,000 sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC Form 4

Evidence

0
CV
Capital V LLC10% Owner
DSPViant Technology Inc.
Option exercise · 10b5-1 plan
M—
37.5K sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC Form 4

Evidence

0
VC
Vanderhook ChristopherDirector, Chief Operating Officer, 10% Owner
DSPViant Technology Inc.
Option exercise · 10b5-1 plan
M—
12.5K sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC Form 4

Evidence

0
VC
Vanderhook ChristopherDirector, Chief Operating Officer, 10% Owner
DSPViant Technology Inc.
Disposition to issuer · 10b5-1 plan
D—
12.5K sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
54.2K sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
12.5K sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC Form 4

Evidence

0
VC
Vanderhook ChristopherDirector, Chief Operating Officer, 10% Owner
DSPViant Technology Inc.
Option exercise · 10b5-1 plan
M—
12.5K sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
33.3K sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC Form 4

Evidence

0
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
12.5K sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC Form 4

Evidence

0
AP
Adarkar PrabirPRESIDENT AND COO
DASHDoorDash, Inc.
Option exercise · 10b5-1 plan
M$72K
10.0K sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC Form 4

Evidence

0
AP
Adarkar PrabirPRESIDENT AND COO
DASHDoorDash, Inc.
Grant or award · 10b5-1 plan
A—
144.3K sh
Apr 20, 2026Apr 22, 2026
traded Apr 20, 2026
+2dSEC Form 4

Evidence